Alcaro S - Search Results

1

Joining European Scientific Forces to Face Pandemics.

Vasconcelos MH, Alcaro S, Arechavala-Gomeza V, Baumbach J, Borges F, Brevini TAL, Rivas JL, Devaux Y, Hozak P, Keinänen-Toivola MM, Lattanzi G, Mohr T, Murovska M, Prusty BK, Quinlan RA, Pérez-Sala D, Scheibenbogen C, Schmidt HHHW, Silveira I, Tieri P, Tolios A, Riganti C. Vasconcelos MH, et al. Among authors: alcaro s. Trends Microbiol. 2021 Feb;29(2):92-97. doi: 10.1016/j.tim.2020.10.008. Epub 2020 Dec 4. Trends Microbiol. 2021. PMID: 33288385 Free PMC article.

2

Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.

Alcaro S, Gaspar A, Ortuso F, Milhazes N, Orallo F, Uriarte E, Yáñez M, Borges F. Alcaro S, et al. Bioorg Med Chem Lett. 2010 May 1;20(9):2709-12. doi: 10.1016/j.bmcl.2010.03.081. Epub 2010 Mar 27. Bioorg Med Chem Lett. 2010. PMID: 20382016

3

Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.

Gaspar A, Silva T, Yáñez M, Vina D, Orallo F, Ortuso F, Uriarte E, Alcaro S, Borges F. Gaspar A, et al. Among authors: alcaro s. J Med Chem. 2011 Jul 28;54(14):5165-73. doi: 10.1021/jm2004267. Epub 2011 Jul 1. J Med Chem. 2011. PMID: 21696156

4

Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors.

Reis J, Cagide F, Chavarria D, Silva T, Fernandes C, Gaspar A, Uriarte E, Remião F, Alcaro S, Ortuso F, Borges F. Reis J, et al. Among authors: alcaro s. J Med Chem. 2016 Jun 23;59(12):5879-93. doi: 10.1021/acs.jmedchem.6b00527. Epub 2016 Jun 10. J Med Chem. 2016. PMID: 27244485

5

Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?

Fonseca A, Reis J, Silva T, Matos MJ, Bagetta D, Ortuso F, Alcaro S, Uriarte E, Borges F. Fonseca A, et al. Among authors: alcaro s. J Med Chem. 2017 Aug 24;60(16):7206-7212. doi: 10.1021/acs.jmedchem.7b00918. Epub 2017 Aug 10. J Med Chem. 2017. PMID: 28753307

6

The Mu.Ta.Lig. Chemotheca: A Community-Populated Molecular Database for Multi-Target Ligands Identification and Compound-Repurposing.

Ortuso F, Bagetta D, Maruca A, Talarico C, Bolognesi ML, Haider N, Borges F, Bryant S, Langer T, Senderowitz H, Alcaro S. Ortuso F, et al. Among authors: alcaro s. Front Chem. 2018 Apr 19;6:130. doi: 10.3389/fchem.2018.00130. eCollection 2018. Front Chem. 2018. PMID: 29725591 Free PMC article.

7

The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease.

Mesiti F, Chavarria D, Gaspar A, Alcaro S, Borges F. Mesiti F, et al. Among authors: alcaro s. Eur J Med Chem. 2019 Nov 1;181:111572. doi: 10.1016/j.ejmech.2019.111572. Epub 2019 Aug 1. Eur J Med Chem. 2019. PMID: 31404859 Review.

8

4-Oxoquinolines and monoamine oxidase: When tautomerism matters.

Mesiti F, Maruca A, Silva V, Rocca R, Fernandes C, Remião F, Uriarte E, Alcaro S, Gaspar A, Borges F. Mesiti F, et al. Among authors: alcaro s. Eur J Med Chem. 2021 Mar 5;213:113183. doi: 10.1016/j.ejmech.2021.113183. Epub 2021 Jan 13. Eur J Med Chem. 2021. PMID: 33493825

9

Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets.

Romeo I, Mesiti F, Lupia A, Alcaro S. Romeo I, et al. Among authors: alcaro s. Molecules. 2021 Jan 26;26(3):632. doi: 10.3390/molecules26030632. Molecules. 2021. PMID: 33530467 Free PMC article. Review.

10

Mapping Chromone-3-Phenylcarboxamide Pharmacophore: Quid Est Veritas?

Mesiti F, Gaspar A, Chavarria D, Maruca A, Rocca R, Gil Martins E, Barreiro S, Silva R, Fernandes C, Gul S, Keminer O, Alcaro S, Borges F. Mesiti F, et al. Among authors: alcaro s. J Med Chem. 2021 Aug 12;64(15):11169-11182. doi: 10.1021/acs.jmedchem.1c00510. Epub 2021 Jul 16. J Med Chem. 2021. PMID: 34269579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page